Ascletis Pharmaceuticals Co., Ltd.
Quick facts
Phase 3 pipeline
- ASC40 · Virology / Hepatology
ASC40 is a hepatitis B virus (HBV) capsid assembly modulator that disrupts viral particle formation. - ASC40 tablets · Virology / Hepatology
ASC40 is a hepatitis B virus (HBV) capsid assembly modulator that disrupts viral particle formation.
Phase 2 pipeline
- ASC22 · Oncology
ASC22 is a humanized monoclonal antibody that blocks the PD-L1 checkpoint, enhancing anti-tumor immune responses by preventing PD-L1 from binding to PD-1 and B7.1 on immune cells. - ih PEG-IFN α-2a
Phase 1 pipeline
- ASC09F
- ASC11 tablets
- ASC18
- ASC41 · Gastroenterology
ASC41 is a thyroid hormone receptor beta (THRβ) agonist that modulates lipid metabolism. - ravidasvir and sofosbuvir
- RTV tablets
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: